Related Experiment Video

Updated: Sep 3, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.6K

Managing Intractable Symptoms of Parkinson's Disease: A Nonsurgical Approach Employing Infralow Frequency

Stella B Legarda1, P Andreas Michas-Martin1, Dana McDermott1

  • 1Montage Health Neurology, Monterey, CA, United States.

Frontiers in Human Neuroscience
|July 26, 2022
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Parkinson's diseasecortical beta suppressionfreezing gait in Parkinson's diseaseinfralow frequency neuromodulation in Parkinson's diseasenon-pharmacological option in advanced Parkinson's diseaseparkinsonismuncontrolled symptoms of Parkinson's diseaseuncontrolled tremors

More Related Videos

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor05:54

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

Published on: December 13, 2017

14.1K
Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain09:35

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain

Published on: May 10, 2017

18.9K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
366
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
690